Stay updated on Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page’s interface revision was updated from v3.5.2 to v3.5.3, reflecting a maintenance/version change to the ClinicalTrials.gov site UI.
    Difference
    0.1%
    Check dated 2026-04-24T05:55:00.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The record history shows a revision bump from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:32:42.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added to the history and revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T06:11:58.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision history now shows v3.4.3 added and v3.4.2 removed.
    Difference
    0.1%
    Check dated 2026-03-12T02:21:42.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history. The funding notice and Revision: v3.4.1 were removed.
    Difference
    0.4%
    Check dated 2026-02-11T11:30:52.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Added a government funding lapse notice with operating status guidance and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:57:30.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.